星昊医药
(430017)
| 流通市值：23.07亿 | | | 总市值：23.31亿 |
| 流通股本：1.21亿 | | | 总股本：1.22亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 255,892,806.05 | 232,515,743.52 | 358,429,374.32 | 375,926,324.75 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 衍生金融资产 | - | - | - | 0 |
| 应收票据及应收账款 | 94,909,430.85 | 78,438,391.22 | 84,763,555.68 | 110,117,515.72 |
| 其中：应收票据 | 10,641,192.44 | 7,370,317.19 | 7,857,798.87 | 17,857,861.55 |
| 应收账款 | 84,268,238.41 | 71,068,074.03 | 76,905,756.81 | 92,259,654.17 |
| 应收款项融资 | 50,849,550.92 | 56,242,253.71 | 771,606.27 | 6,118,938.52 |
| 预付款项 | 3,848,798.5 | 3,996,738.33 | 6,914,457.37 | 2,779,738.14 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 4,012,475.15 | 3,815,171.93 | 8,070,663.4 | 8,038,210.4 |
| 其中:应收利息 | - | - | - | 0 |
| 应收股利 | - | - | - | 0 |
| 买入返售金融资产 | - | - | - | 0 |
| 存货 | 73,204,801.66 | 80,168,385.88 | 68,115,898.47 | 60,591,812.03 |
| 合同资产 | - | - | - | 0 |
| 一年内到期的非流动资产 | - | - | - | 0 |
| 其他流动资产 | 1,157,699.89 | 798,123.77 | 2,737,329.94 | 1,455,155.48 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 982,566,267.12 | 979,569,165.91 | 936,613,056.69 | 936,380,215.59 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | - | 0 |
| 债权投资 | - | - | - | 0 |
| 其他债权投资 | - | - | - | 0 |
| 长期应收款 | - | - | - | 0 |
| 长期股权投资 | 7,922,419.99 | 8,054,811.17 | 8,254,042.05 | 8,410,266.32 |
| 其他权益工具投资 | 9,259,671.37 | 9,259,671.37 | 9,259,671.37 | 9,259,671.37 |
| 其他非流动金融资产 | - | - | - | 0 |
| 投资性房地产 | - | - | - | 0 |
| 固定资产 | 623,284,659.97 | 633,880,672.48 | 638,661,078.15 | 640,381,903.69 |
| 在建工程 | 48,934,849.09 | 43,210,161.84 | 26,541,719.85 | 25,486,347.34 |
| 生产性生物资产 | - | - | - | 0 |
| 油气资产 | - | - | - | 0 |
| 使用权资产 | - | - | - | 0 |
| 无形资产 | 77,081,592.32 | 78,977,525.33 | 59,567,320.72 | 39,712,795.16 |
| 开发支出 | - | - | - | 0 |
| 商誉 | - | - | - | 0 |
| 长期待摊费用 | 106,880.87 | 394,952.93 | 452,921.6 | 561,742.85 |
| 递延所得税资产 | 30,323,639.98 | 33,051,567.72 | 34,477,758.75 | 33,465,413.23 |
| 其他非流动资产 | 107,386,247.56 | 102,660,115.75 | 115,031,887.24 | 106,129,782.23 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 904,299,961.15 | 909,489,478.59 | 892,246,399.73 | 863,407,922.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,886,866,228.27 | 1,889,058,644.5 | 1,828,859,456.42 | 1,799,788,137.78 |
| 流动负债: | | | | |
| 短期借款 | 13,447,993.49 | 20,398,949.89 | 10,007,181.57 | 10,506,688.55 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | - | - | - | 0 |
| 衍生金融负债 | - | - | - | 0 |
| 应付票据及应付账款 | 115,232,620.46 | 117,084,472.01 | 52,790,473.29 | 41,247,533.03 |
| 其中：应付票据 | 64,723,570 | 69,748,750 | 8,044,750 | 5,572,260 |
| 应付账款 | 50,509,050.46 | 47,335,722.01 | 44,745,723.29 | 35,675,273.03 |
| 预收款项 | - | - | - | 0 |
| 合同负债 | 48,872,302.39 | 48,581,087.13 | 62,677,150.48 | 50,923,143.32 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 7,315,959.02 | 7,450,863.04 | 10,064,325.71 | 15,266,226.93 |
| 应交税费 | 8,698,601.21 | 8,074,774.09 | 10,410,437.99 | 14,556,120.85 |
| 其他应付款合计 | 54,434,620.79 | 57,190,088.22 | 48,689,067.1 | 46,139,938.65 |
| 其中:应付利息 | - | - | - | 0 |
| 应付股利 | - | - | - | 0 |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | - | - | - | 0 |
| 其他流动负债 | 6,734,078.05 | 7,867,696.65 | 9,580,936.71 | 16,321,760.57 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 254,736,175.41 | 266,647,931.03 | 204,219,572.85 | 194,961,411.9 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 0 |
| 应付债券 | - | - | - | 0 |
| 优先股 | - | - | - | 0 |
| 永续债 | - | - | - | 0 |
| 租赁负债 | - | - | - | 0 |
| 长期应付款 | - | - | - | 0 |
| 长期应付职工薪酬 | - | - | - | 0 |
| 预计负债 | - | - | - | 0 |
| 递延收益 | 104,917,693.27 | 109,452,872.63 | 116,548,121.74 | 120,983,242.87 |
| 递延所得税负债 | 1,709,348.36 | 1,806,618.65 | 1,537,230.62 | 1,491,748.09 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 106,627,041.63 | 111,259,491.28 | 118,085,352.36 | 122,474,990.96 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 361,363,217.04 | 377,907,422.31 | 322,304,925.21 | 317,436,402.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 122,577,200 | 122,577,200 | 122,577,200 | 122,577,200 |
| 其他权益工具 | - | - | - | 0 |
| 优先股 | - | - | - | 0 |
| 永续债 | - | - | - | 0 |
| 资本公积 | 713,346,683.96 | 713,346,683.96 | 713,346,683.96 | 713,346,683.96 |
| 减:库存股 | 21,239,402.81 | 18,219,402.81 | 18,219,402.81 | 18,219,402.81 |
| 其他综合收益 | -787,834.3 | -785,773.1 | -786,399.4 | -786,625.81 |
| 专项储备 | - | - | - | 0 |
| 盈余公积 | 44,223,186.94 | 44,223,186.94 | 44,223,186.94 | 44,223,186.94 |
| 一般风险准备 | - | - | - | 0 |
| 未分配利润 | 667,383,177.44 | 649,041,666.07 | 643,975,225.17 | 619,022,388.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,525,503,011.23 | 1,510,183,561.06 | 1,505,116,493.86 | 1,480,163,430.66 |
| 少数股东权益 | - | 967,661.13 | 1,438,037.35 | 2,188,304.26 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,525,503,011.23 | 1,511,151,222.19 | 1,506,554,531.21 | 1,482,351,734.92 |
| 负债和股东权益合计 | 1,886,866,228.27 | 1,889,058,644.5 | 1,828,859,456.42 | 1,799,788,137.78 |
| 公告日期 | 2024-10-28 | 2024-08-26 | 2024-04-26 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |